LaFleur & Godfrey’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.1M Sell
126,245
-5,552
-4% -$1.29M 3.81% 4
2026
Q1
$32.2M Sell
131,797
-2,970
-2% -$692K 4.01% 4
2025
Q4
$27.9M Sell
134,767
-5,370
-4% -$1.06M 3.38% 4
2025
Q3
$26M Sell
140,137
-3,498
-2% -$599K 3.15% 5
2025
Q2
$21.9M Buy
143,635
+4,782
+3% +$735K 2.74% 7
2025
Q1
$23M Buy
138,853
+8,964
+7% +$1.4M 3.12% 6
2024
Q4
$18.8M Sell
129,889
-5,138
-4% -$796K 2.58% 7
2024
Q3
$21.9M Buy
135,027
+3,338
+3% +$532K 3.02% 5
2024
Q2
$19.2M Buy
131,689
+3,570
+3% +$531K 2.82% 7
2024
Q1
$20.3M Buy
128,119
+2,492
+2% +$397K 3% 5
2023
Q4
$19.7M Buy
125,627
+6,709
+6% +$1.03M 2.94% 6
2023
Q3
$18.5M Buy
118,918
+5,585
+5% +$922K 2.97% 7
2023
Q2
$18.8M Buy
113,333
+3,531
+3% +$570K 2.81% 8
2023
Q1
$17M Sell
109,802
-1,084
-1% -$175K 2.79% 7
2022
Q4
$19.6M Sell
110,886
-1,649
-1% -$285K 3.27% 6
2022
Q3
$18.4M Sell
112,535
-8,148
-7% -$1.38M 3.28% 5
2022
Q2
$21.4M Sell
120,683
-1,043
-0.9% -$186K 3.39% 5
2022
Q1
$21.6M Sell
121,726
-14,362
-11% -$2.44M 2.9% 6
2021
Q4
$23.3M Sell
136,088
-883
-0.6% -$145K 2.99% 6
2021
Q3
$22.1M Buy
136,971
+9,080
+7% +$1.55M 3.06% 6
2021
Q2
$21.1M Buy
127,891
+26,938
+27% +$4.46M 3.02% 6
2021
Q1
$16.6M Buy
100,953
+635
+0.6% +$103K 3.23% 6
2020
Q4
$15.8M Sell
100,318
-3,510
-3% -$518K 3.23% 6
2020
Q3
$15.5M Buy
103,828
+7,150
+7% +$1.06M 3.49% 6
2020
Q2
$13.6M Sell
96,678
-1,304
-1% -$190K 3.47% 8
2020
Q1
$12.8M Buy
97,982
+227
+0.2% +$32.2K 3.83% 4
2019
Q4
$14.3M Buy
97,755
+1,445
+2% +$196K 3.22% 9
2019
Q3
$12.5M Sell
96,310
-3,209
-3% -$423K 3.05% 10
2019
Q2
$13.9M Buy
99,519
+1,575
+2% +$218K 3.46% 10
2019
Q1
$13.7M Buy
97,944
+375
+0.4% +$50.2K 3.53% 11
2018
Q4
$12.6M Buy
97,569
+8,890
+10% +$1.24M 3.55% 9
2018
Q3
$12.3M Buy
88,679
+265
+0.3% +$35.2K 2.95% 12
2018
Q2
$10.7M Buy
88,414
+10,798
+14% +$1.35M 2.68% 15
2018
Q1
$9.95M Sell
77,616
-312
-0.4% -$42.2K 2.49% 16
2017
Q4
$10.9M Buy
77,928
+80
+0.1% +$11.1K 2.67% 13
2017
Q3
$10.1M Sell
77,848
-2,796
-3% -$371K 2.65% 10
2017
Q2
$10.7M Buy
80,644
+582
+0.7% +$74.2K 2.81% 10
2017
Q1
$9.97M Sell
80,062
-173
-0.2% -$20.7K 2.69% 10
2016
Q4
$9.24M Buy
80,235
+2,761
+4% +$319K 2.59% 12
2016
Q3
$9.15M Sell
77,474
-1,143
-1% -$139K 2.64% 12
2016
Q2
$9.54M Buy
78,617
+357
+0.5% +$40.6K 2.82% 13
2016
Q1
$8.47M Buy
78,260
+5,367
+7% +$556K 2.57% 13
2015
Q4
$7.49M Buy
72,893
+872
+1% +$87.7K 2.22% 12
2015
Q3
$6.72M Buy
72,021
+1,776
+3% +$172K 2.01% 13
2015
Q2
$6.85M Buy
70,245
+2,417
+4% +$242K 1.89% 15
2015
Q1
$6.82M Sell
67,828
-1,618
-2% -$165K 1.83% 16
2014
Q4
$7.26M Sell
69,446
-723
-1% -$76.2K 1.94% 15
2014
Q3
$7.48M Sell
70,169
-3,199
-4% -$332K 2.05% 15
2014
Q2
$7.68M Sell
73,368
-8,813
-11% -$891K 2.04% 16
2014
Q1
$8.07M Sell
82,181
-3,186
-4% -$295K 2.23% 16
2013
Q4
$7.82M Sell
85,367
-10,136
-11% -$934K 2.15% 15
2013
Q3
$8.28M Sell
95,503
-3,030
-3% -$272K 2.38% 15
2013
Q2
$8.46M Buy
+98,533
New +$8.36M 2.52% 12

Other funds holding JNJ

LaFleur & Godfrey's JNJ Position: Q2 2026 in Review

LaFleur & Godfrey reduced its Johnson & Johnson (JNJ) stake by 4.2% in Q2 2026, selling an estimated $1.29M and leaving 126,245 shares worth $32.1M. The position accounts for 3.81% of the portfolio, ranked #4.

LaFleur & Godfrey first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $32.2M in Q1 2026. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • LaFleur & Godfrey held 126,245 shares of Johnson & Johnson worth $32.1M as of Q2 2026.
  • LaFleur & Godfrey sold 5,552 Johnson & Johnson shares in Q2 2026, an estimated $1.29M.
  • Johnson & Johnson made up 3.81% of LaFleur & Godfrey's portfolio in Q2 2026, its #4 holding.
  • LaFleur & Godfrey first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • LaFleur & Godfrey's Johnson & Johnson position peaked at $32.2M in Q1 2026.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on LaFleur & Godfrey's 13F filing for Q2 2026, filed 15 Jul 2026.